References
- Warnakulasuriya, S.,: Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 45, 309-316. (2009). https://doi.org/10.1016/j.oraloncology.2008.06.002
- Papadimitrakopoulou, V.A., et al.,: Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience. Cancer J Sci Am. 3, 92-99. (1997).
- Shen, J., et al.,: Enhancement of cisplatin induced apoptosis by suberoylanilide hydroxamic acid in human oral squamous cell carcinoma cell lines. Biochem Pharmacol. 73, 1901-1909. (2007). https://doi.org/10.1016/j.bcp.2007.03.009
- Koehn, F.E. and G.T. Carter,: The evolving role of natural products in drug discovery. Nat Rev Drug Discov. 4, 206-220. (2005). https://doi.org/10.1038/nrd1657
- Butler, M.S.,: The role of natural product chemistry in drug discovery. J Nat Prod. 67, 2141-2153. (2004). https://doi.org/10.1021/np040106y
- Lee, H.B., J.C. Kim, and S.M. Lee,: Antibacterial activity of two phloroglucinols, flavaspidic acids AB and PB, from Dryopteris crassirhizoma. Arch Pharm Res. 32, 655-659. (2009). https://doi.org/10.1007/s12272-009-1502-9
- Chang, X., et al.,: Phenolic constituents from the rhizomes of Dryopteris crassirhizoma. Chem Pharm Bull (Tokyo). 54, 748-750. (2006). https://doi.org/10.1248/cpb.54.748
- Magalhaes, L.G., et al.,: In vitro schistosomicidal effects of some phloroglucinol derivatives from Dryopteris species against Schistosoma mansoni adult worms. Parasitol Res. 106, 395-401. (2010). https://doi.org/10.1007/s00436-009-1674-8
- Ban, S.H., et al.,: Influences of Dryopteris crassirhizoma extract on the viability, growth and virulence properties of Streptococcus mutans. Molecules. 17, 9231-9244. (2012). https://doi.org/10.3390/molecules17089231
- Chang, S.H., et al.,: Dryopteris crassirhizoma has anti-cancer effects through both extrinsic and intrinsic apoptotic pathways and G0/G1 phase arrest in human prostate cancer cells. J Ethnopharmacol. 130, 248-254. (2010). https://doi.org/10.1016/j.jep.2010.04.038
- Yu, H.J., et al.,: Apoptotic effect of dibenzylideneacetone on oral cancer cells via modulation of specificity protein 1 and Bax. Oral Dis. 19, 767-774. (2013). https://doi.org/10.1111/odi.12062
- Igney, F.H. and P.H. Krammer,: Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer. 2, 277-288. (2002). https://doi.org/10.1038/nrc776
- Leber, B., J. Lin, and D.W. Andrews,: Embedded together: the life and death consequences of interaction of the Bcl-2 family with membranes. Apoptosis. 12, 897-911. (2007). https://doi.org/10.1007/s10495-007-0746-4
- Jin, Z. and W.S. El-Deiry,: Overview of cell death signaling pathways. Cancer Biol Ther. 4, 139-163. (2005).
- Labi, V., et al.,: BH3-only proteins in cell death initiation, malignant disease and anticancer therapy. Cell Death Differ. 13, 1325-1338. (2006). https://doi.org/10.1038/sj.cdd.4401940